Targeted Drug Delivery Infographic
What is a targeted drug delivery system?
A targeted drug delivery system is a medical device or method that delivers therapeutic agents—such as drugs, biologics, or nanoparticles—directly to specific tissues, cells, or organs. This approach increases treatment precision, reduces side effects, and improves patient outcomes.
Why is targeted drug delivery important?
Targeted drug delivery enables localized treatment of diseases, especially in oncology, neurology, and autoimmune disorders. By focusing the therapy where it’s needed most, these systems improve efficacy and minimize systemic exposure.
What does the infographic include?
The infographic includes:
- 11 anatomical delivery sites, including brain, eyes, respiratory tract, skin, and GI tract
- 57 drug delivery methods mapped to route and drug modality
- Real-world device examples in use or clinical trials
- Delivery technologies for small molecules, biologics, cell therapies, nanoparticles, and more
Who should download the drug delivery infographic?
This guide is designed for:
- Drug delivery system developers
- Biotech and pharma product managers
- Medical device R&D teams
- Regulatory and clinical affairs professionals
- Combination product developers
Download the Drug Delivery Infographic
Frequently Asked Questions
Are the devices shown FDA-approved?
Many of the drug delivery devices and technologies listed are FDA-approved or CE-marked, while others are in active development or clinical trials. The infographic provides a clear indication of both commercially available and emerging technologies.
Is the infographic free to download?
Yes. The Guide to Targeted Drug Delivery Systems infographic is completely free. Simply fill out the download form to receive instant access to the PDF.
How can this infographic support my product development?
This infographic serves as a visual reference and strategic tool. It helps teams explore delivery options by tissue type, identify potential technology partners, and inform design and regulatory planning for combination products and targeted therapies.